Thailand’s National Vaccine Institute (NVI) has formed a partnership with the US Vaccine Research Centre (VRC) to develop vaccines against tuberculosis, including those utilising Messenger RNA (mRNA) technology. The collaboration was announced following a visit by senior officials from Thailand’s Public Health Ministry to the VRC on April 20.
The VRC is a leading global organisation in vaccine research and has successfully developed 15 vaccine types for various diseases, including influenza, Covid-19, Ebola, Zika fever, and tuberculosis. The visitors were greeted by Richard Koup, the VRC deputy director, within the framework of the National Institute of Allergy and Infectious Diseases.
According to the Thai government, the country’s Department of Medical Sciences and NVI are determined to work with the US VRC to create a new tuberculosis vaccine. Thailand…
